State Street Global Advi... Quote - SYI

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

30.06

Bid

29.98

Ask

30.08

Volume

20,804

29.82 Day's Range 30.08

0.00 52 Week Range 0.00

Market Cap

Previous Close

29.68

Open

29.82

Last Trade

30.08

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

35.98M

Net Profit

34.82M

Sector

Investors, Nec

Industry

Investors, Nec

Website

www.spdr.com.au

Headquarters

Sydney, New South Wales, Aus

Founded

State Street Global Advisors Australia Services Ltd is listed in the Investors sector of the Australian Stock Exchange with ticker SYI. The last closing price for State Street Global Advi... was AUD29.68. Over the last year, State Street Global Advi... shares have traded in a share price range of AUD 0.00 to AUD 0.00.

State Street Global Advi... currently has 0 shares outstanding.

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE

MONTVALE, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that it has entered into agreements with the current holders of its Series...

Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update

MONTVALE, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that, following a review of its clinical development portfolio and its...

Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium

MONTVALE, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has completed enrollment of its BENEFICIAL study, a Phase 2 double-blind...

Synvista Notified by NYSE Alternext of Continued Listing Standards Non-Compliance

Company Expects Its Common Stock to Remain Listed While it Engages in Compliance Process MONTVALE, N.J., Dec. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI...

Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline

Synvista Therapeutics Technology Provided CML Biomarker Data for Studies MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BCTBriaCell Therapeutics Corp	$ 1.09 (28.24%)	73.59k
TLGTroilus Gold Corp	$ 0.33 (26.92%)	1.17M
NUMINuminus Wellness Inc	$ 0.05 (25.00%)	618.71k
IAUi80 Gold Corp	$ 0.94 (20.51%)	2.67M
LEVLion Electric Company	$ 0.32 (18.52%)	2.17M
CRWNCrown Capital Partners Inc	$ 1.05 (-17.32%)	400
BUBurcon NutraScience Corporation	$ 0.13 (-16.13%)	480.26k
KRNKarnalyte Resources Inc	$ 0.12 (-14.29%)	4.8k
EGLXEnthusiast Gaming Holdings Inc	$ 0.155 (-11.43%)	242.22k
YRBYorbeau Resources Inc	$ 0.04 (-11.11%)	52.8k
ENBEnbridge Inc	$ 60.80 (1.64%)	12.84M
SUSuncor Energy Inc	$ 57.47 (0.65%)	12.58M
CNQCanadian Natural Resources Ltd	$ 48.32 (2.35%)	11.12M
BITFBitfarms Ltd	$ 2.86 (-5.61%)	7.76M
CVECenovus Energy Inc	$ 22.63 (0.04%)	7.6M